Article: The Importance of Training and Continuity in Direct-to-Patient Services

By Kelly Frend |

When your therapeutic product is delivered and administered to patients at home, how can you ensure that required procedures are executed consistently each time? What if a different nurse or driver is assigned to your patient?

The answer lies in the thorough training of all frontline staff who play a role in relation to Direct-to-Patient (DtP) services.

The nursing partner is responsible for all study- or program-specific training, completed on a country-by-country basis, covering all aspects of the protocol through to Good Clinical Practice (GCP).

To gauge the importance of training for your logistics partner, a thorough understanding of their role is required:

The role of the logistics partner in DtP

In addition to detailed SOPs related to temperature-controlled packing, shipping, training and DtP, additional SOPs should address issues such as:

  • Regulatory compliance for DtP including GxP (Good Practice) adherence
  • Patient confidentiality (dispatch, blinding of documentation, invoicing and related requirements)
  • Driver communications with patients and nurses
  • Packaging and labelling
  • Identification of recipients
  • Data retention and destruction
  • Contingency planning
  • Protocol support

Service excellence is only as good as the weakest link. Continuous training and thorough SOPs eliminates any weak links and should be a priority when implementing DtP services.

Download our DtP e-book

Find out more about the other critical considerations when implementing DtP services

Download the DtP e-book here

About the Author

Kelly Frend

Specialty Services Manager
World Courier
Kelly is Specialty Services Manager and Subject Matter Expert for Direct-to-Patient and Cell and Gene Therapy at World Courier. Kelly has nearly 14 years of experience within the specialty transport and logistics industry. At World Courier, Kelly is a subject matter expert in temperature-controlled logistics, with a deep knowledge of Direct-to-Patient and Cell and Gene Therapy supply chains. She is responsible for leading the WEMEA region by overseeing all specialty service offerings within this area. She maintains a thorough understanding of the regulatory landscape and drives improvement initiatives that ensure all customers receive the highest level of service at all times.
View Bio